{"id":"F2007B01053","name":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 15 of 2000)","slug":"national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-15-of-2000","collection":"legislative_instrument","jurisdiction":"commonwealth","status":"repealed","isInForce":false,"actNumber":null,"makingDate":null,"administeringDepartment":null,"currentVersion":{"id":62533,"registerId":"commonwealth-F2007B01053-current","compilationNumber":null,"startDate":"2026-04-02","status":"Repealed","reasons":null,"registeredAt":null},"sections":[{"sectionNumber":"1","sectionType":"section","heading":"National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 15 of 2000)","content":"COMMONWEALTH OF AUSTRALIA\n\nNational Health Act 1953\n\nPHARMACEUTICAL BENEFITS\n\nDECLARATION UNDER SUBSECTION 85 (2AA)\n\nNo. PB 15 of 2000\n\nI, BRETT ANTHONY LENNON, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Aged Care and Delegate of the Minister for Health and Aged Care, having in accordance with subsection 85 (2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85 (2AA) of the National Health Act 1953, hereby make the following Declaration:\n\n1.  This Declaration shall come into operation on 1 November 2000.\n\n2. The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.\n\nTHE SCHEDULE\n\nChlorothiazide\n\nCodeine Phosphate with Aspirin\n\nDienoestrol\n\nFluoxymesterone\n\nDated this 7th day of October 2000.\n\nBRETT ANTHONY LENNON\n\nAssistant Secretary\n\nPharmaceutical Benefits Branch\n\nDepartment of Health and Aged Care\n\nDelegate of the Minister for Health and Aged Care","sortOrder":0}],"analysis":{"kimi_summary":{"_metrics":{"model":"kimi-k2.5","source":"moonshot-batch","completionTokens":2071},"content_quality":"ok","complexity_score":1,"scope_assessment":{"changed":false,"description":"This declaration operates strictly within the original administrative purpose of subsection 85(2AA) of the National Health Act 1953, which authorises the removal of specific drugs from the Pharmaceutical Benefits Scheme following expert advice. There is no expansion beyond this standard delisting function."},"complexity_factors":["Extremely short instrument (single page)","No defined terms requiring interpretation","Simple, unilateral operative effect (delisting)","Limited scope to four specific chemical entities","No conditional logic, exceptions, or cross-references beyond the enabling Act section"],"plain_english_summary":"This declaration removes four prescription medicines — chlorothiazide, codeine phosphate with aspirin, dienoestrol and fluoxymesterone — from Australia’s Pharmaceutical Benefits Scheme effective 1 November 2000. Affected patients lose PBS subsidy and must pay full private prices. The Assistant Secretary of the Pharmaceutical Benefits Branch made the change acting on advice from the PBAC."}},"importantCases":[],"_links":{"self":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-15-of-2000","history":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-15-of-2000/history","analysis":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-15-of-2000/analysis","conflicts":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-15-of-2000/conflicts","importantCases":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-15-of-2000/important-cases","documents":"/api/acts/national-health-act-1953-declaration-under-subsection-85-2aa-no-pb-15-of-2000/documents"}}